HOLLY BOTTOMS: Open Payments
NPI 1538547609 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 22 payments from 10 companies in 2025. Trend: 2023 $82 · 2024 $218 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $110 |
| ABBVIE INC. | 4 | $83 |
| PFIZER INC. | 3 | $59 |
| Lilly USA, LLC | 2 | $42 |
| Inspire Medical Systems, Inc. | 2 | $34 |
| Boston Scientific Corporation | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Medtronic, Inc. | 1 | $23 |
| Indivior Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: Wegovy, VRAYLAR, MOUNJARO, Ozempic, ELIQUIS, INSPIRE, WATCHMAN Access System, QULIPTA.
Industry payments across GA — which companies pay providers there.
